Butyrate augments interferon-α-induced S phase accumulation and persistent tyrosine phosphorylation of cdc2 in K562 cells

British Journal of Cancer

Volumn 79, Issue 7-8, 1999, Pages 1018-1024

  Miyachi, T ^a   Adachi, M ^a   Hinoda, Y ^a   Imai, K ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Butyrate; cdc2; IFN ; S phase accumulation; Tyrosine phosphorylation

Indexed keywords

ALPHA INTERFERON; BUTYRIC ACID; CYTOKINE; PROTEIN KINASE;

ARTICLE; CANCER CHEMOTHERAPY; CELL CYCLE S PHASE; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; BUTYRATES; CDC2 PROTEIN KINASE; CELL DIFFERENTIATION; DRUG SYNERGISM; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; K562 CELLS; PHOSPHORYLATION; S PHASE; TYROSINE;

EID: 0032986443     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690163     Document Type: Article

References (37)

1. Adachi M, Sekiya M, Ishino M, Sasaki H, Hinoda Y, Imai K and Yachi A (1994) Induction of protein tyrosine phosphatase LC-PTP by IL-2 in human T cells: LC-PTP is an early response gene. FEBS Let 338: 47-52
2. Adachi M, Ishino M, Torigoe T, Minami Y, Matozaki T, Miyazaki T, Taniguchi T, Hinoda Y and Imai K (1997) Interleukin-2 induces tyrosine phosphorylation of SHP-2 through IL-2 receptor β chain. Oncogene 14: 1629-1633
3. Anderson LC, Jokinen M and Gahmberg CG (1979) Induction of erythroid differentiation in the human leukemia cell line K562. Nature (Lond) 278: 364-365
4. Balkwill FR, Mowshowitz S, Seilman SS, Moodie EM, Griffin DB, Fantes KH and Wolf CR (1984) Positive interactions between interferon and chemotherapy due to direct tumor action rather than effects on host drug-metabolizing enzymes. Cancer Res 44: 5249-5255
5. 1-accumulation. Blood 89: 2938-2950.
6. Calabresse C, Venturini L, Ronco G, Villa P, Chomienne C and Belpomme D (1993) Butyric acid and its monosaccharide ester induce apoptosis in the HL-60 cell line. Biochem Biophys Res Commun 195: 31-38
7. Dale TC, Iman AMA, Kerr IM and Stark GR (1989) Rapid activation by interferon alpha of a latent DNA binding protein present in the cytoplasm of untreated cells. Proc Natl Acad Sci USA 86: 1203-1207
8. Darnell JE, Kerr IM and Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421
9. 1 arrest. Nature 313: 597-600
10. Enoch T and Nurse P (1990) Mutation of fission yeast cell cycle control genes abolishes dependence of mitosis on DNA replication. Cell 60: 665-673
11. Farrar MA and Schreiber RD (1993) The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol 11: 571-579
12. wee 1 mitotic inhibitor is a tyrosine/serine kinase. Nature 349: 808-811
13. - protein kinase regulates entry into mitosis. Nature 342: 39-45
14. Gutterman JU (1994) Cytokine therapeutics: lessons from interferon α. Proc Natl Acad Sci USA 91: 1198-1205
15. Hague A, Manning AM, Hanlon KA, Nuschtscha LI, Hart D and Paraskeva C (1993) Sodium butyrate induces apoptosis in human colonic tumor cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer 55: 498-505
16. Jin P, Gu Y and Morgan DO (1996) Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells. J Cell Biol 134: 963-970
17. Krupitza G, Harant H, Dittrich E, Szekeres T, Huber H and Dittrich C (1995) Sodium butyrate inhihils c-myc splicing and interferes with signal transduction in ovarian carcinoma cells. Carcinogenesis 16: 1199-1205
18. Lengyel P (1982) Biochemistry of interferons and their actions. Annu Rev Biochem 51: 251-282
19. Leung S. Qureshi SA, Kerr IM, Darnell JE and Stark GR (1995) Role of STAT2 in the alpha interferon signalling pathway. Mol Cell Biol 15: 1312-1317
20. Lundgren K, Walworth N, Booher R, Dembski M, Kirschner M and Beach D (1991) mik 1 and wee 1 cooperate in the inhibitory tyrosine phosphorylation of cdc2. Cell 64: 1111-1122
21. McBain JA, Eastman A, Simmons DL, Pettit GR and Mueller GC (1996) Phorbol ester augments butyrate-induced apoptosis of colon cancer cells. Int J Cancer 67: 715-723
22. cdc2 protein kinase during mitosis. Cell 58: 361-372
23. Nurse P (1990) Universal control mechanism regulating onset of M phase. Nature 344: 503-508
24. Oberg K (1992) The action of interferon κ on human carcinoid tumors. Semin Cancer Biol 3: 35-41
25. Ogura M, Morishima Y, Ohno R, Kato Y, Hirabayashi N, Nagura H and Saito H (1985) Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome. Blood 66: 1384-1392
26. Ozer H, George SL, Schiffer CA, Rao K, Rao PN, Wurster-Hill DH, Arther DD, Powell B, Gottlieb A, Peterson BA, Rai K, Testa JR, LeBeau M, Tantravahi R and Bloomfield CD (1993) Prolonged subcutaneous administration of recombinant α-2β interferon in patients with previously untreated Philadelphia chromosome-positive chronic phase myclogenous leukemia: effect on remission duration and survival. Cancer and Leukemia Group B Study 8583. Blood 82: 2975-2984
27. Qin X-Q, Runkel L, Deck C, DeDios C and Barsoum J (1997) Interferon-β induces S phase accumulation selectively in human transformed cells. J Interferon Cytokine Res 17: 355-367
28. Reeder JA Dickinson JL, Chenevix-Trench G and Antalis TM (1993) Sodium butyrate differentially modulates plasminogen activator inhibitor type-I, urokinase plasminogen activator and its receptor in a human colon carcinoma cell. Teratog Carcinog Mutagen 13: 75-88
29. Resnitzky D, Tiefenbrun N, Berissi H and Kimchi A (1992) Interferon and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells. Proc Natl Acad Sci USA 89: 402-406
30. Russo GL, Pietra VD, Mercurio C, Ragione FD, Marshak DR, Oliva A and Zappia V (1997) Down-regulation of protein kinase CKII activity by sodium butyrate. Biochem Biophys Res Commun 233: 673-677
31. Sherr CJ (1993) Mammalian G1 cyclins. Cell 73 1059-1065
32. Stahl N, Farruggella TJ, Boulton TG, Zhong Z, Darnell JE and Yancopoulos GD (1995) Choices of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptor. Science 267: 1349-1353
33. cdc2/cyclin B complex in vitro by human CDC25 protein. Nature 351: 242-245
34. Sugimoto K, Toyoshima H, Sakai R, Miyagawa K, Hagiwara K, Ishikawa F, Takaku F, Yazaki Y and Hirai H (1992) Frequent mutations in the p53 gene in human myeloid leukemia cell lines. Blood 79: 2378-2383
35. Tiefenbrun N, Melamed D, Levy N, Resnitzky D, Hoffmann I, Reed S and Kimchi A (1996) Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest. Mol Cell Biol 16: 3934-3944
36. Wadler S and Schwartz EL (1990) Antineoplastic activity of the combination of interferon and cylotoxic agents against experimental and human malignancies: a review. Cancer Res 50: 3473-3486
37. Yan H, Krishnan K, Greenlund AC, Gupta S, Lim JTE, Schreiber RD, Schindler CW and Krolewski JJ (1996) Phosphorylated interferon-a receptor I subunit (IFNAR1) acts as a docking site for the latent form of the 113 kDa Stat2 protein. EMBO J 15: 1064-1074